Serial 79449818
Live / Allowed — Approved for publication (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Feb 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 79449818
- Mark type
- Design / logo
- Filed
- 18 Feb 2026
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- Novartis AG, CH
Prosecution history
- 08 Sept 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 08 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Sept 2026 — EXAMINER'S AMENDMENT ENTERED
- 08 Sept 2026 — EXAMINERS AMENDMENT E-MAILED
- 08 Sept 2026 — EXAMINERS AMENDMENT -WRITTEN
- 04 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Sept 2026 — REFUSAL PROCESSED BY IB
- 14 Aug 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 14 Aug 2026 — REFUSAL PROCESSED BY MPU
- 12 Jun 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 11 Jun 2026 — NON-FINAL ACTION WRITTEN
- 09 Jun 2026 — ASSIGNED TO EXAMINER
- 07 Jun 2026 — APPLICATION FILING RECEIPT MAILED